You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Raloxifene and tamoxifen had similar efficacy for preventing invasive breast cancer in women at increased risk

https://doi.org/10.1136/ebm.11.6.177

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • ↵* See glossary.

    • For correspondence: Dr V G Vogel, University of Pittsburgh, Pittsburgh, PA, USA. vvogel{at}magee.edu

    • Sources of funding: National Cancer Institute; AstraZeneca; Eli Lilly.

    Linked Articles

    • Glossary
      Glossary
      BMJ Publishing Group Ltd
      BMJ Evidence-Based Medicine 2006; 11 191-191 Published Online First: 30 Nov 2006. doi: 10.1136/ebm.11.6.191-a